» Articles » PMID: 35690734

Alpha-smooth Muscle Actin-positive Cancer-associated Fibroblasts Secreting Osteopontin Promote Growth of Luminal Breast Cancer

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cancer-associated fibroblasts (CAFs) have been shown to support tumor development in a variety of cancers. Different markers were applied to classify CAFs in order to elucidate their impact on tumor progression. However, the exact mechanism by which CAFs enhance cancer development and metastasis is yet unknown.

Methods: Alpha-smooth muscle actin (α-SMA) was examined immunohistochemically in intratumoral CAFs of nonmetastatic breast cancers and correlated with clinicopathological data. Four CAF cell lines were isolated from patients with luminal breast cancer (lumBC) and classified according to the presence of α-SMA protein. Conditioned medium (CM) from CAF cultures was used to assess the influence of CAFs on lumBC cell lines: MCF7 and T47D cells using Matrigel 3D culture assay. To identify potential factors accounting for promotion of tumor growth by α-SMA CAFs, nCounter PanCancer Immune Profiling Panel (NanoString) was used.

Results: In luminal breast cancer, presence of intratumoral CAFs expressing high level of α-SMA (13% of lumBC group) correlated with poor prognosis (p = 0.019). In in vitro conditions, conditioned medium obtained from primary cultures of α-SMA-positive CAFs isolated from luminal tumors was observed to enhance growth of lumBC cell line colonies in 3D Matrigel, in contrast to CM derived from α-SMA-negative CAFs. Multigene expression analysis indicated that osteopontin (OPN) was overexpressed in α-SMA-positive CAFs in both clinical samples and in vitro models. OPN expression was associated with higher percentage of Ki67-positive cells in clinical material (p = 0.012), while OPN blocking in α-SMA-positive CAF-derived CM attenuated growth of lumBC cell line colonies in 3D Matrigel.

Conclusions: Our findings demonstrate that α-SMA-positive CAFs might enhance tumor growth via secretion of OPN.

Citing Articles

Mechanistic insights into Uc001kfo-induced hepatocellular carcinoma metastasis.

Pan Y, Liu Q, Li Q, Ren Z Discov Oncol. 2025; 16(1):260.

PMID: 40025303 PMC: 11872824. DOI: 10.1007/s12672-025-02000-9.


Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms.

Singaravelan N, Tollefsbol T Nutrients. 2025; 17(4).

PMID: 40004944 PMC: 11858336. DOI: 10.3390/nu17040616.


Therapeutic effects of quercetin in oral cancer therapy: a systematic review of preclinical evidence focused on oxidative damage, apoptosis and anti-metastasis.

Saadh M, Ahmed H, Chandra M, Al-Hussainy A, Hamid J, Mishra A Cancer Cell Int. 2025; 25(1):66.

PMID: 39994659 PMC: 11854426. DOI: 10.1186/s12935-025-03694-1.


TGF-β signaling orchestrates cancer-associated fibroblasts in the tumor microenvironment of human hepatocellular carcinoma: unveiling insights and clinical significance.

Ge J, Jiang H, Chen J, Chen X, Zhang Y, Shi L BMC Cancer. 2025; 25(1):113.

PMID: 39838288 PMC: 11753146. DOI: 10.1186/s12885-025-13435-2.


Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy.

Zhang Z, Wang R, Chen L Int J Nanomedicine. 2025; 20():483-503.

PMID: 39816375 PMC: 11734509. DOI: 10.2147/IJN.S500591.


References
1.
Bartoschek M, Oskolkov N, Bocci M, Lovrot J, Larsson C, Sommarin M . Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. 2018; 9(1):5150. PMC: 6279758. DOI: 10.1038/s41467-018-07582-3. View

2.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

3.
Hu G, Xu F, Zhong K, Wang S, Huang L, Chen W . Activated Tumor-infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients. J Cancer. 2018; 9(20):3736-3742. PMC: 6216016. DOI: 10.7150/jca.28054. View

4.
Zhao H, Chen Q, Alam A, Cui J, Suen K, Pac Soo A . The role of osteopontin in the progression of solid organ tumour. Cell Death Dis. 2018; 9(3):356. PMC: 5834520. DOI: 10.1038/s41419-018-0391-6. View

5.
Lee Y, Tan Y, Falasca M, Oon C . Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer. Cancers (Basel). 2020; 12(10). PMC: 7600259. DOI: 10.3390/cancers12102949. View